Patent details

EP3172209 Title: TABLET FORMULATION OF 2-FLUORO-N-METHYL-4-[7-(QUINOLIN-6-YLMETHYL)IMIDAZO[1,2-B][1,2,4]TRIAZIN-2-YL]BENZAMIDE

Basic Information

Publication number:
EP3172209
PCT Application Number:
IB2015055561
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP157447020
PCT Publication Number:
WO2016012963
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
TABLET FORMULATION OF 2-FLUORO-N-METHYL-4-[7-(QUINOLIN-6-YLMETHYL)IMIDAZO[1,2-B][1,2,4]TRIAZIN-2-YL]BENZAMIDE
French Title of Invention:
FORMULATION DE COMPRIMÉ DE 2-FLUORO-N-MÉTHYL-4-[7-(QUINOLINE -6-YLMÉTHYL) IMIDAZO[1,2-B][1,2,4]TRIAZINE -2-YL]BENZAMIDE
German Title of Invention:
TABLETTENFORMULIERUNG VON 2-FLUOR-N-METHYL-4-[7- (CHINOLIN-6-YLMETHYL)IMIDAZO[1,2-B] [1,2,4]TRIAZIN-2-YL]BENZAMID
SPC Number:

Dates

Filing date:
22/07/2015
Grant date:
02/12/2020
EP Publication Date:
31/05/2017
PCT Publication Date:
28/01/2016
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
02/12/2020
EP B1 Publication Date:
02/12/2020
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
22/07/2021
Expiration date:
22/07/2035
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
25/11/2020
 
 

Name:
Novartis AG
Address:
Lichtstrasse 35, 4056 Basel, Switzerland (CH)

Inventor

1

Name:
GONCALVES, Elisabete
Address:
Switzerland (CH)

2

Name:
ZONG, Zhixin
Address:
United States (US)

3

Name:
TAUCHMANN, Christin
Address:
Switzerland (CH)

4

Name:
YEN, Shau-fong
Address:
Switzerland (CH)

5

Name:
VIPPAGUNTA, Sudha
Address:
United States (US)

Priority

Priority Number:
201462028865 P
Priority Date:
25/07/2014
Priority Country:
United States (US)

Classification

IPC classification:
A61J 3/06; A61J 3/10; A61K 31/4985; A61P 35/00; C07D 487/04;

Publication

European Patent Bulletin

1

Issue number:
202049
Publication date:
02/12/2020
Description:
Grant (B1)

2

Issue number:
202424
Publication date:
12/06/2024
Description:
Opposition rejected; Patent maintained as granted

3

Issue number:
202101
Publication date:
06/01/2021
Description:
Application number/publication number of the divisional application (Art. 76) changed

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages